Biopharma looks to single-cell RNAseq1 for biomarker discovery, to identify targets that can personalize therapy and increase efficacy. Most scRNAseq technologies require complex equipment that is too expensive for sample collection sites, forcing biopharma to rely on cryopreservation to ship samples to advanced research labs across the globe. Cryopreservation damages fragile and sparse cells, biasing samples—what you freeze is not what you thaw.
The HIVE™ scRNAseq Solution enables scRNAseq studies with global sample collection and centralized lab processing. Technicians at collection sites can gently and reproducibly capture single cells from fragile or sparse samples. As you ship your samples worldwide, the HIVE™ scRNAseq Solution locks the single-cell molecular signature as if it was fresh, giving researchers access to single-cell resolution for samples collected across the globe.